Edit this postWhat Do Brokerages Indicate About ITC’s Earnings Recovery and Future Valuation?
About the Company
ITC Limited, one of India’s largest conglomerates, operates across diversified verticals including FMCG, cigarettes, hotels, paperboards, and agribusiness. With a strong brand portfolio and integrated supply chain, ITC continues to balance its traditional tobacco strength with fast-growing FMCG and hotel segments. Its capital-efficient structure and consistent dividend payout have made it a defensive favorite among investors seeking stability with moderate growth.
Recent Performance and Financial Highlights
| Metric | Q2 FY26 | YoY Change | Comment |
|---|---|---|---|
| Revenue | ₹18,021 Cr | ↓ 3% | Weak agri performance offset steady growth in FMCG and cigarettes. |
| EBITDA | ₹6,250 Cr | ↑ 2% | Margin expansion in FMCG and paper aided profitability. |
| EBITDA Margin | 34.68% | +185 bps | Improved operational leverage and pricing support margins. |
| Net Profit | ₹5,179 Cr | ↑ 2% | Strong cash generation sustained dividend potential. |
Brokerage Ratings and Key Takeaways
| Brokerage | Rating | Target Price (₹) | Remarks |
|---|---|---|---|
| Citi | Buy | 500 | Sees 6% cigarette volume growth; expects FY27 margin recovery supported by tax moderation. |
| Goldman Sachs | Buy | 490 | Broadly in line; expects faster margin recovery as raw material costs ease. |
| Morgan Stanley | Overweight | 469 | Expects resilience in cigarettes, improving FMCG profitability, and steady paper EBIT margins. |
Peer Comparison
| Company | P/E (x) | ROE (%) | EBITDA Margin (%) | Revenue Growth (YoY) |
|---|---|---|---|---|
| ITC | 24.3 | 28.1 | 34.7 | -3% |
| HUL | 57.8 | 27.4 | 23.5 | 6% |
| Godrej Consumer | 51.5 | 23.6 | 20.2 | 7% |
| Marico | 50.5 | 22.9 | 17.2 | 4% |
SWOT Analysis
| Strengths | Weaknesses | Opportunities | Threats |
|---|---|---|---|
| Diverse business model with strong cash flow generation. | Slow growth in agri and paper divisions. | Premium FMCG growth and hotel expansion post-demerger. | Tax volatility and ESG scrutiny on tobacco. |
Valuation and Verdict
ITC trades at ~24x FY26E EPS, a discount to FMCG peers, making it attractive on relative valuation. The stock’s risk-reward remains favorable due to consistent cash flows, dividend yield, and the gradual turnaround in its non-cigarette portfolio. Analysts expect stable earnings CAGR of 9–10% through FY27.
Verdict:
Short Term (1–3 months): Range-bound; maintain watch near ₹440–460 levels.
Medium Term (6–12 months): Hold; dividend yield (~3.5%) supports downside.
Long Term (2–3 years): Accumulate; improving FMCG traction and hotel demerger could unlock valuation premium.
Investor Takeaway
ITC remains a defensive compounder with attractive valuation, strong cash generation, and improving non-cigarette mix. Investors may use market dips for gradual accumulation while monitoring FMCG margin expansion and hotel monetization developments. Stay tuned to Nifty Option Tip updates for tracking sectoral shifts influencing FMCG-heavy indices.
Discover more equity insights at Indian-Share-Tips.com, which is a SEBI Registered Advisory Services.
SEBI Disclaimer: The information provided in this post is for informational purposes only and should not be construed as investment advice. Readers must perform their own due diligence and consult a registered investment advisor before making any investment decisions.
